These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 36551096)
1. Smart Nanostructured Materials for SARS-CoV-2 and Variants Prevention, Biosensing and Vaccination. Wang L; Li Z Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551096 [TBL] [Abstract][Full Text] [Related]
2. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
9. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta. Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999 [TBL] [Abstract][Full Text] [Related]
10. Hierarchical Nanobiosensors at the End of the SARS-CoV-2 Pandemic. Medrano-Lopez JA; Villalpando I; Salazar MI; Torres-Torres C Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392027 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic. Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300 [TBL] [Abstract][Full Text] [Related]
12. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19. Li Q; Wang J; Tang Y; Lu H Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination. Graninger M; Camp JV; Aberle SW; Traugott MT; Hoepler W; Puchhammer-Stöckl E; Weseslindtner L; Zoufaly A; Aberle JH; Stiasny K Front Immunol; 2022; 13():888794. PubMed ID: 35711424 [TBL] [Abstract][Full Text] [Related]
14. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 in Southeast Asia: current status and perspectives. Chu DT; Vu Ngoc SM; Vu Thi H; Nguyen Thi YV; Ho TT; Hoang VT; Singh V; Al-Tawfiq JA Bioengineered; 2022 Feb; 13(2):3797-3809. PubMed ID: 35081861 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History. Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006 [TBL] [Abstract][Full Text] [Related]
18. Development of chemiluminescent lab-on-fiber immunosensors for rapid point-of-care testing of anti-SARS-CoV-2 antibodies and evaluation of longitudinal immune response kinetics following three-dose inactivation virus vaccination. Xu W; Song D; Liu J; Han X; Xu J; Zhu A; Long F J Med Virol; 2023 Jan; 95(1):e28190. PubMed ID: 36180404 [TBL] [Abstract][Full Text] [Related]